Anúncio
Anúncio
ZBIO
Zenas BioPharma, Inc. Common Stock
16.09
USDPatrocinado
-0.32
-1.98%
09 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
16.15
+0.06
+0.40%
Relatórios de Lucros ZBIO
Rácio de surpresa positiva
ZBIO separação 2 de 5 últimas estimativas.
40%
Próximo Relatório
Data do Próximo Relatório
09 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$39.10M
/-$1.04
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/-14.75%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+682.00%
/-73.93%
Zenas BioPharma, Inc. Common Stock earnings per share and revenue
On 12 de nov. de 2025, ZBIO reported earnings of -1.22 USD per share (EPS) for Q3 25, missing the estimate of -1.06 USD, resulting in a -14.17% surprise. Revenue reached --, compared to an expected 10.20 milhão, with a -100.00% difference. The market reacted with a +1.70% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 analistas forecast an EPS of -1.04 USD, with revenue projected to reach 39.10 milhão USD, implying an diminuir of -14.75% EPS, and -- of --% in Revenue from the last quarter.
FAQ
What were Zenas BioPharma, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Zenas BioPharma, Inc. Common Stock reported EPS of -$1.22, missing estimates by -14.17%, and revenue of $0.00, -100% below expectations.
How did the market react to Zenas BioPharma, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 1.7%, changed from $35.20 before the earnings release to $35.80 the day after.
When is Zenas BioPharma, Inc. Common Stock expected to report next?
The next earning report is scheduled for 09 de mar. de 2026.
What are the forecasts for Zenas BioPharma, Inc. Common Stock's next earnings report?
Based on 8
analistas, Zenas BioPharma, Inc. Common Stock is expected to report EPS of -$1.04 and revenue of $39.10M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio